NCT02970877 - Allogenic Fecal Microbiota Transplantation (FMT) vs Autologous FMT & Adiposity / Obesity

Study overview

NCT02970877 - Allogenic Fecal Microbiota Transplantation (FMT) vs Autologous FMT & Adiposity / Obesity is a randomized clinical phase II treatment trial to study Allogenic Fecal Microbiota Transplantation (FMT) or Autologous FMTin patients with morbidly obese (BMI >40 kg/m² or BMI >35-40 kg/m² with other severe weight loss responsive comorbidities)

Primary outcome measures

Change in Insulin Resistance Compared to Baseline

Results

For NCT02970877 - Allogenic Fecal Microbiota Transplantation (FMT) vs Autologous FMT & Adiposity / Obesity, as of February 2026 there is no yet publicly available full results article